Search Results

You searched for : Empagliflozin

	CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure. ... May 20
	US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction Latest Pharma News Update... Aug 23
	Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type ... Jan 07
	Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial ... Nov 19
	Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets Empagliflozin and Linagliptin tablets, have an estimated market size of US$ 244 million for twelve months ending June 2020... Aug 27
	Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets Alembic receives USFDA approval for their erectile dysfunction drug ... Aug 05
	USFDA gives tentative nod to Zydus for Empagliflozin tablets The medication is used to improve blood sugar control in adults with Type 2 diabetes mellitus, along with diet and exercise.... Apr 13
	Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors Post-hoc analysis of the EMPA-REG OUTCOMEÂ® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ... Sep 20
8 Matching result(s) found!

-Advertisements-

Trending Now
	Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
	Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
	Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
	Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
	Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
	Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
	Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
	Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
	TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
	The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
	Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024
	The Future of Healthcare: 10 ways Telehealth is Improving Patient Outcomes and Reducing CostsMay 03, 2024
	Understanding the Effects of a Keto Diet on Your Body: A One-Month JourneyMay 03, 2024
	High Blood Pressure in Youth: A Precursor to Severe Heart ConditionsMay 03, 2024
	High Blood Pressure in Youth: A Precursor to Severe Heart ConditionsMay 03, 2024
	Microplastics in Human Brains: Understanding the Emerging Health ConcernMay 03, 2024
	Federal Bank Wraps Up FY 24 With 24% Rise in Profit, highest NII, Maintains Robust Asset QualityMay 02, 2024
	Two Aveksha Day Care Centers for Construction Workers’ Children opened on the occasion of Labour Day May 02, 2024
	AbbVie India and Sightsavers India Collaborate to Raise Awareness on GlaucomaMay 02, 2024
	Whither social justice and decent work for women?May 02, 2024

Search Results

CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure.

US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction

Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets

Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial

Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets

Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets

USFDA gives tentative nod to Zydus for Empagliflozin tablets

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Trending Now